Literature DB >> 20307489

Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs).

Vladimir P Skulachev1, Yury N Antonenko, Dmitry A Cherepanov, Boris V Chernyak, Denis S Izyumov, Ludmila S Khailova, Sergey S Klishin, Galina A Korshunova, Konstantin G Lyamzaev, Olga Yu Pletjushkina, Vitaly A Roginsky, Tatiana I Rokitskaya, Fedor F Severin, Inna I Severina, Ruben A Simonyan, Maxim V Skulachev, Natalia V Sumbatyan, Evgeniya I Sukhanova, Vadim N Tashlitsky, Tatyana A Trendeleva, Mikhail Yu Vyssokikh, Renata A Zvyagilskaya.   

Abstract

The present state of the art in studies on the mechanisms of antioxidant activities of mitochondria-targeted cationic plastoquinone derivatives (SkQs) is reviewed. Our experiments showed that these compounds can operate as antioxidants in two quite different ways, i.e. (i) by preventing peroxidation of cardiolipin [Antonenko et al., Biochemistry (Moscow) 73 (2008) 1273-1287] and (ii) by fatty acid cycling resulting in mild uncoupling that inhibits the formation of reactive oxygen species (ROS) in mitochondrial State 4 [Severin et al. Proc. Natl. Acad. Sci. USA 107 (2009), 663-668]. The quinol and cationic moieties of SkQ are involved in cases (i) and (ii), respectively. In case (i) SkQH2 interrupts propagation of chain reactions involved in peroxidation of unsaturated fatty acid residues in cardiolipin, the formed SkQ- being reduced back to SkQH2 by heme bH of complex III in an antimycin-sensitive way. Molecular dynamics simulation showed that there are two stable conformations of SkQ1 with the quinol residue localized near peroxyl radicals at C9 or C13 of the linoleate residue in cardiolipin. In mechanism (ii), fatty acid cycling mediated by the cationic SkQ moiety is involved. It consists of (a) transmembrane movement of the fatty acid anion/SkQ cation pair and (b) back flows of free SkQ cation and protonated fatty acid. The cycling results in a protonophorous effect that was demonstrated in planar phospholipid membranes and liposomes. In mitochondria, the cycling gives rise to mild uncoupling, thereby decreasing membrane potential and ROS generation coupled to reverse electron transport in the respiratory chain. In yeast cells, dodecyltriphenylphosphonium (capital ES, Cyrillic12TPP), the cationic part of SkQ1, induces uncoupling that is mitochondria-targeted since capital ES, Cyrillic12TPP is specifically accumulated in mitochondria and increases the H+ conductance of their inner membrane. The conductance of the outer cell membrane is not affected by capital ES, Cyrillic12TPP.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307489     DOI: 10.1016/j.bbabio.2010.03.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

1.  Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells.

Authors:  Brian D Fink; Judith A Herlein; Mark A Yorek; Amanda M Fenner; Robert J Kerns; William I Sivitz
Journal:  J Pharmacol Exp Ther       Date:  2012-06-01       Impact factor: 4.030

Review 2.  Redox regulation of mitochondrial function.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-02-03       Impact factor: 8.401

3.  Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids berberine and palmatine.

Authors:  Konstantin G Lyamzaev; Antonina V Pustovidko; Ruben A Simonyan; Tatyana I Rokitskaya; Lidia V Domnina; Olga Yu Ivanova; Inna I Severina; Natalia V Sumbatyan; Galina A Korshunova; Vadim N Tashlitsky; Vitaly A Roginsky; Yuriy N Antonenko; Maxim V Skulachev; Boris V Chernyak; Vladimir P Skulachev
Journal:  Pharm Res       Date:  2011-06-14       Impact factor: 4.200

Review 4.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

Review 5.  "Only a Life Lived for Others Is Worth Living": Redox Signaling by Oxygenated Phospholipids in Cell Fate Decisions.

Authors:  Yulia Y Tyurina; Indira Shrivastava; Vladimir A Tyurin; Gaowei Mao; Haider H Dar; Simon Watkins; Michael Epperly; Ivet Bahar; Anna A Shvedova; Bruce Pitt; Sally E Wenzel; Rama K Mallampalli; Yoel Sadovsky; Dmitry Gabrilovich; Joel S Greenberger; Hülya Bayır; Valerian E Kagan
Journal:  Antioxid Redox Signal       Date:  2017-10-16       Impact factor: 8.401

Review 6.  Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.

Authors:  Giuseppe Paradies; Valeria Paradies; Francesca M Ruggiero; Giuseppe Petrosillo
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 7.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 8.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

Review 9.  Evolution of cytochrome bc complexes: from membrane-anchored dehydrogenases of ancient bacteria to triggers of apoptosis in vertebrates.

Authors:  Daria V Dibrova; Dmitry A Cherepanov; Michael Y Galperin; Vladimir P Skulachev; Armen Y Mulkidjanian
Journal:  Biochim Biophys Acta       Date:  2013-07-19

Review 10.  Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

Authors:  Ru Wen; Bhabatosh Banik; Rakesh K Pathak; Anil Kumar; Nagesh Kolishetti; Shanta Dhar
Journal:  Adv Drug Deliv Rev       Date:  2016-01-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.